• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-214 通过下调 RNF8 抑制乳腺癌细胞的上皮-间充质转化。

miR-214 inhibits epithelial-mesenchymal transition of breast cancer cells via downregulation of RNF8.

机构信息

Department of Biology and Chemistry, College of Liberal Arts and Sciences, National University of Defense Technology, Changsha, China.

出版信息

Acta Biochim Biophys Sin (Shanghai). 2019 Aug 5;51(8):791-798. doi: 10.1093/abbs/gmz067.

DOI:10.1093/abbs/gmz067
PMID:31294443
Abstract

MicroRNAs (miRNAs) are a class of endogenous noncoding genes that regulate gene expression at the posttranscriptional level. In recent decades, miRNAs have been reported to play important roles in tumor growth and metastasis, while some reported functions of a specific miRNA in tumorigenesis are contradictory. In this study, we reevaluated the role of miR-214, which has been reported to serve as an oncogene or anti-oncogene in breast cancer metastasis. We found that miR-214 inhibited breast cancer via targeting RNF8, a newly identified regulator that could promote epithelial-mesenchymal transition (EMT). Specifically, the survival rate of breast cancer patients was positively correlated with miR-214 levels and negatively correlated with RNF8 expression. The overexpression of miR-214 inhibited cell proliferation and invasion of breast cancer, while suppression of miR-214 by chemically modified antagomir enhanced the proliferation and invasion of breast cancer cells. Furthermore, miR-214 could modulate the EMT process via downregulating RNF8. To our knowledge, this is the first report that reveals the role of the miR-214-RNF8 axis in EMT, and our results demonstrate a novel mechanism for miR-214 acting as a tumor suppressor through the regulation of EMT.

摘要

微小 RNA(miRNA)是一类内源性非编码基因,可在转录后水平调节基因表达。近几十年来,已有研究报道 miRNAs 在肿瘤生长和转移中发挥重要作用,而某些特定 miRNA 在肿瘤发生中的作用则相互矛盾。在这项研究中,我们重新评估了 miR-214 的作用,已有研究报道 miR-214 可作为乳腺癌转移的癌基因或抑癌基因。我们发现 miR-214 通过靶向 RNF8 抑制乳腺癌,RNF8 是一种新发现的可促进上皮-间充质转化(EMT)的调控因子。具体而言,乳腺癌患者的生存率与 miR-214 水平呈正相关,与 RNF8 表达呈负相关。miR-214 的过表达抑制了乳腺癌细胞的增殖和侵袭,而通过化学修饰的反义寡核苷酸抑制 miR-214 的表达则增强了乳腺癌细胞的增殖和侵袭。此外,miR-214 可通过下调 RNF8 来调节 EMT 过程。据我们所知,这是首次报道 miR-214-RNF8 轴在 EMT 中的作用,我们的研究结果表明 miR-214 通过调节 EMT 作为肿瘤抑制因子的一种新机制。

相似文献

1
miR-214 inhibits epithelial-mesenchymal transition of breast cancer cells via downregulation of RNF8.miR-214 通过下调 RNF8 抑制乳腺癌细胞的上皮-间充质转化。
Acta Biochim Biophys Sin (Shanghai). 2019 Aug 5;51(8):791-798. doi: 10.1093/abbs/gmz067.
2
RNF8 promotes epithelial-mesenchymal transition of breast cancer cells.RNF8促进乳腺癌细胞的上皮-间质转化。
J Exp Clin Cancer Res. 2016 Jun 4;35(1):88. doi: 10.1186/s13046-016-0363-6.
3
miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.miR-381 通过靶向 CXCR4 抑制乳腺癌细胞增殖、上皮间质转化和转移。
Biomed Pharmacother. 2017 Feb;86:426-433. doi: 10.1016/j.biopha.2016.12.051. Epub 2016 Dec 21.
4
PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer.miR-21对PIK3R1的靶向作用通过降低PI3K/AKT信号传导和逆转上皮-间质转化来抑制肿瘤细胞迁移和侵袭,并可预测乳腺癌的临床结局。
Int J Oncol. 2016 Feb;48(2):471-84. doi: 10.3892/ijo.2015.3287. Epub 2015 Dec 10.
5
miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.miR-448 通过直接靶向 E-钙黏蛋白抑制因子 ZEB1/2 抑制乳腺癌细胞的上皮-间充质转化。
Exp Biol Med (Maywood). 2018 Mar;243(5):473-480. doi: 10.1177/1535370218754848. Epub 2018 Jan 25.
6
The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer.miR-644a/CTBP1/p53轴通过同时抑制乳腺癌细胞的存活和上皮-间质转化来抑制耐药性。
Oncotarget. 2016 Aug 2;7(31):49859-49877. doi: 10.18632/oncotarget.10489.
7
Regulation of cell growth and migration by miR-96 and miR-183 in a breast cancer model of epithelial-mesenchymal transition.miR-96 和 miR-183 通过上皮间质转化调控乳腺癌模型中的细胞生长和迁移。
PLoS One. 2020 May 12;15(5):e0233187. doi: 10.1371/journal.pone.0233187. eCollection 2020.
8
miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.miR-671-5p通过下调乳腺癌中FOXM1的表达来抑制上皮-间质转化。
Oncotarget. 2016 Jan 5;7(1):293-307. doi: 10.18632/oncotarget.6344.
9
MicroRNA-548m Suppresses Cell Migration and Invasion by Targeting Aryl Hydrocarbon Receptor in Breast Cancer Cells.微小 RNA-548m 通过靶向乳腺癌细胞中的芳香烃受体抑制细胞迁移和侵袭。
Oncol Res. 2021 Mar 16;28(6):615-629. doi: 10.3727/096504020X16037933185170. Epub 2020 Oct 27.
10
miR-1236 regulates hypoxia-induced epithelial-mesenchymal transition and cell migration/invasion through repressing SENP1 and HDAC3.微小RNA-1236通过抑制小泛素样修饰蛋白激活酶1和组蛋白去乙酰化酶3来调控缺氧诱导的上皮-间质转化及细胞迁移/侵袭。
Cancer Lett. 2016 Aug 1;378(1):59-67. doi: 10.1016/j.canlet.2016.05.006. Epub 2016 May 10.

引用本文的文献

1
Exploring the molecular mechanisms of comorbidity between thyroid cancer and breast cancer through multi-omics data.通过多组学数据探索甲状腺癌和乳腺癌共病的分子机制。
Sci Rep. 2025 Jul 2;15(1):23309. doi: 10.1038/s41598-025-06566-w.
2
Hsa-miR-214-3p inhibits breast cancer cell growth and improves the tumor immune microenvironment by downregulating B7H3.人源微小RNA-214-3p通过下调B7H3抑制乳腺癌细胞生长并改善肿瘤免疫微环境。
Oncol Res. 2024 Dec 20;33(1):103-121. doi: 10.32604/or.2024.057472. eCollection 2025.
3
Identification of differentially expressed circRNAs in prostate cancer of different clinical stages by RNA sequencing.
通过 RNA 测序鉴定不同临床阶段前列腺癌中的差异表达 circRNAs。
Sci Rep. 2023 Dec 1;13(1):21175. doi: 10.1038/s41598-023-48521-7.
4
Association of high miR-27a, miR-206, and miR-214 expression with poor patient prognosis and increased chemoresistance in triple-negative breast cancer.高表达的miR-27a、miR-206和miR-214与三阴性乳腺癌患者预后不良及化疗耐药性增加相关。
Am J Cancer Res. 2023 Jun 15;13(6):2471-2487. eCollection 2023.
5
MicroRNAs as Potential Tools for Predicting Cancer Patients' Susceptibility to SARS-CoV-2 Infection and Vaccination Response.微小 RNA 可作为预测癌症患者对 SARS-CoV-2 感染和疫苗接种反应易感性的潜在工具。
Cells. 2022 Jul 23;11(15):2279. doi: 10.3390/cells11152279.
6
A functional reference map of the RNF8 interactome in cancer.癌症中 RNF8 相互作用组的功能参考图谱。
Biol Direct. 2022 Jul 13;17(1):17. doi: 10.1186/s13062-022-00331-z.
7
Comprehensive Analysis of hsa-miR-654-5p's Tumor-Suppressing Functions.hsa-miR-654-5p 的抑瘤功能综合分析
Int J Mol Sci. 2022 Jun 8;23(12):6411. doi: 10.3390/ijms23126411.
8
Epi-miRNAs: Regulators of the Histone Modification Machinery in Human Cancer.Epi - 微小RNA:人类癌症中组蛋白修饰机制的调节因子
J Oncol. 2022 Jan 11;2022:4889807. doi: 10.1155/2022/4889807. eCollection 2022.
9
MicroRNA-214 in Health and Disease.miR-214 在健康与疾病中的作用
Cells. 2021 Nov 23;10(12):3274. doi: 10.3390/cells10123274.
10
MicroRNAs in Epithelial-Mesenchymal Transition Process of Cancer: Potential Targets for Chemotherapy.微小 RNA 在癌症上皮间质转化过程中的作用:化疗的潜在靶点。
Int J Mol Sci. 2021 Jul 14;22(14):7526. doi: 10.3390/ijms22147526.